Literature DB >> 3532540

Evaluation of HLA-haplotype disparate parental marrow grafts depleted of T lymphocytes by differential agglutination with a soybean lectin and E-rosette depletion for the treatment of severe combined immunodeficiency.

R J O'Reilly, J Brochstein, N Collins, C Keever, N Kapoor, D Kirkpatrick, N Kernan, B Dupont, J Burns, Y Reisner.   

Abstract

The factors that impact upon successful bone marrow transplantation leading to immunologic reconstitution in severe combined immune deficiency (SCID). Wiskott-Aldrich syndrome, and in other lethal congenital immunodeficiencies are reviewed. Evidence is presented that graft-versus-host disease (GVHD) can be abrogated by the depletion of T cells, even from histoincompatible marrow grafts. However, graft resistance or restricted immune reconstitution has been observed with significant frequency. The bases for T cell reconstitution and limitations in B cell humoral immune recovery in the postgrafting period are reviewed, together with emerging evidence that pretransplant cytoreduction might obviate some of these problems.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3532540     DOI: 10.1111/j.1423-0410.1986.tb02013.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  11 in total

1.  The effect of natural killer cell killer Ig-like receptor alloreactivity on the outcome of bone marrow stem cell transplantation for severe combined immunodeficiency (SCID).

Authors:  M D Keller; D F Chen; S A Condron; N Liu; N L Reinsmoen; R H Buckley
Journal:  J Clin Immunol       Date:  2006-12-27       Impact factor: 8.317

Review 2.  Novel strategies for adoptive therapy following HLA disparate transplants.

Authors:  Richard J O'Reilly; Aisha Hasan; Ekaterina Doubrovina; Guenther Koehne; Susan Prockop
Journal:  Best Pract Res Clin Haematol       Date:  2011-09       Impact factor: 3.020

Review 3.  Immune reconstitution following bone marrow transplantation.

Authors:  U N Verma; A Mazumder
Journal:  Cancer Immunol Immunother       Date:  1993-11       Impact factor: 6.968

Review 4.  Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes.

Authors:  Rebecca H Buckley
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

Review 5.  Graft-versus-host disease.

Authors:  James L M Ferrara; John E Levine; Pavan Reddy; Ernst Holler
Journal:  Lancet       Date:  2009-03-11       Impact factor: 79.321

6.  Development of multiple monoclonal serum immunoglobulins (multiclonal gammopathy) following both HLA-identical unfractionated and T cell-depleted haploidentical bone marrow transplantation in severe combined immunodeficiency.

Authors:  E F Kent; J Crawford; H J Cohen; R H Buckley
Journal:  J Clin Immunol       Date:  1990-03       Impact factor: 8.317

7.  Transplantation outcomes for severe combined immunodeficiency, 2000-2009.

Authors:  Sung-Yun Pai; Brent R Logan; Linda M Griffith; Rebecca H Buckley; Roberta E Parrott; Christopher C Dvorak; Neena Kapoor; Imelda C Hanson; Alexandra H Filipovich; Soma Jyonouchi; Kathleen E Sullivan; Trudy N Small; Lauri Burroughs; Suzanne Skoda-Smith; Ann E Haight; Audrey Grizzle; Michael A Pulsipher; Ka Wah Chan; Ramsay L Fuleihan; Elie Haddad; Brett Loechelt; Victor M Aquino; Alfred Gillio; Jeffrey Davis; Alan Knutsen; Angela R Smith; Theodore B Moore; Marlis L Schroeder; Frederick D Goldman; James A Connelly; Matthew H Porteus; Qun Xiang; William T Shearer; Thomas A Fleisher; Donald B Kohn; Jennifer M Puck; Luigi D Notarangelo; Morton J Cowan; Richard J O'Reilly
Journal:  N Engl J Med       Date:  2014-07-31       Impact factor: 91.245

Review 8.  Advances in the understanding and treatment of human severe combined immunodeficiency.

Authors:  R H Buckley
Journal:  Immunol Res       Date:  2000       Impact factor: 4.505

Review 9.  Defining success with cellular therapeutics: the current landscape for clinical end point and toxicity analysis.

Authors:  Leslie S Kean
Journal:  Blood       Date:  2018-05-04       Impact factor: 25.476

Review 10.  Structure-function and application of plant lectins in disease biology and immunity.

Authors:  Abtar Mishra; Assirbad Behura; Shradha Mawatwal; Ashish Kumar; Lincoln Naik; Subhashree Subhasmita Mohanty; Debraj Manna; Puja Dokania; Amit Mishra; Samir K Patra; Rohan Dhiman
Journal:  Food Chem Toxicol       Date:  2019-09-19       Impact factor: 6.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.